Rare Bleeding Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
  • Rare Bleeding Disorders Home
    • Products
      Our Treatments How to Order Trial Prescriptions Recombinant Manufacturing
    • Professional Resources
      Product Resources Library Contact Your Representative
    • Disease Education
      Clinical Education Library Congenital Hemophilia with Inhibitors Acquired Hemophilia Glanzmann's Thrombasthenia Interactive Joint Bleed Model
    • Treatment Guidelines
      MASAC Guidelines WFH Guidelines
    • Additional Resources
      Organizations & Conferences
    • Product Education
      Product Education Materials
    • Disease Education
      Disease Education Resources
    • Access & Affordability
      Prescription Savings & Insurance Support
  • Sign In
    Create Account
    • Account Settings
    • Sign Out
    Other Therapy Areas
    Medical Information
    Non-US Health Care Professionals

Teach patients to quickly identify and treat joint bleeds.

Educate patients and caretakers about the possible consequences of delaying joint bleed treatment with this interactive animated video. Roll over hotspots to reveal additional information about pain management, surgery and more.

This patient-friendly animation focuses on the knee to:

Engage patients with hemophilia in a physiological overview of joint bleeds

Underscore the importance of prompt on-demand treatments

Roll over hotspots for more information

Prompt treatment of joint bleeds is vital.

Using treatments as prescribed helps patients control acute hemarthrosis and avoid chronic joint issues down the line, such as synovitis and permanent hemophilic arthropathy. Left unmanaged or untreated, these may eventually require surgical interventions.1-3

Learn about a potential on-demand treatment.

Explore now

More resources for you and your patients

MASAC guidelines

Guidelines icon

Review MASAC guidance for emergency department staff who may see patients present with a rare bleeding disorder.

Find out more

MASAC= Medical and Scientific Advisory Council of the National Hemophilia Foundation

Resources library icon

Clinical Education Library

More of the latest rare bleeding disorders information at your fingertips.

Find out more
Resources library icon

Patient Support

Discover educational resources for hemophilia patients and caretakers.

Browse resources

Have questions? Contact your local Novo Nordisk Representative

References:

  1. Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020:26(Suppl 6):1-158.
  2. Luck JV, Silva M, Rodrigues-Merchan EC, et al. Hemophilic arthropathy. J Am Acad Orthop Surg. 2004;12:234-245.
  3. Lafeber FP, Miossec P, Valentino LA. Physiopathology of haemophilic arthropathy. Haemophilia. 2008;14(Suppl 4):3-9.
Rare Bleeding Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
  • Rare Bleeding Disorders Home
  • Product Information
    Products
    • Our Treatments
      How to Order
      Trial Prescriptions
      Recombinant Manufacturing
    Professional Resources
    • Product Resources Library
      Contact Your Representative
  • Professional Education
    Disease Education
    • Clinical Education Library
      Congenital Hemophilia with Inhibitors
      Acquired Hemophilia
      Glanzmann's Thrombasthenia
      Interactive Joint Bleed Model
    Treatment Guidelines
    • MASAC Guidelines
      WFH Guidelines
    Additional Resources
    • Organizations & Conferences
  • Patient Support
    Product Education
    • Product Education Materials
    Disease Education
    • Disease Education Resources
    Access & Affordability
    • Prescription Savings & Insurance Support

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to pro.novonordisk.com.

Legal Notice | Privacy Policy | Cookie Policy | Contact Us |
novonordisk-us.com    
© 2022 Novo Nordisk All rights reserved. US22HRBD00022 April 2022

Quick links

Trial prescription programs

Patient access and affordability options

MASAC treatment guidelines

Patient educational materials